IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.349
AS - Asia 11.787
EU - Europa 10.780
SA - Sud America 2.802
AF - Africa 335
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 28
Totale 45.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.308
SG - Singapore 4.613
RU - Federazione Russa 3.453
CN - Cina 2.875
BR - Brasile 2.202
IT - Italia 1.855
VN - Vietnam 1.790
GB - Regno Unito 1.758
HK - Hong Kong 899
DE - Germania 838
CA - Canada 744
UA - Ucraina 625
FR - Francia 435
SE - Svezia 317
FI - Finlandia 272
DK - Danimarca 271
IN - India 269
AR - Argentina 224
NL - Olanda 214
MX - Messico 207
BD - Bangladesh 196
IE - Irlanda 190
IL - Israele 177
PL - Polonia 175
TR - Turchia 159
ID - Indonesia 126
EC - Ecuador 122
ES - Italia 111
PK - Pakistan 109
IQ - Iraq 108
JP - Giappone 107
ZA - Sudafrica 107
AT - Austria 70
MA - Marocco 62
UZ - Uzbekistan 60
CO - Colombia 59
VE - Venezuela 52
CL - Cile 42
AE - Emirati Arabi Uniti 39
LT - Lituania 39
PH - Filippine 36
PY - Paraguay 33
SA - Arabia Saudita 32
KE - Kenya 31
TN - Tunisia 28
EU - Europa 27
EG - Egitto 26
PE - Perù 24
UY - Uruguay 23
RO - Romania 20
CH - Svizzera 19
DZ - Algeria 18
AU - Australia 17
JO - Giordania 17
MY - Malesia 17
AZ - Azerbaigian 16
BE - Belgio 16
HN - Honduras 15
NP - Nepal 15
TH - Thailandia 14
KG - Kirghizistan 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
PS - Palestinian Territory 12
GR - Grecia 11
JM - Giamaica 11
PT - Portogallo 11
CZ - Repubblica Ceca 10
KR - Corea 10
CR - Costa Rica 9
NI - Nicaragua 9
NZ - Nuova Zelanda 9
PA - Panama 8
TW - Taiwan 8
BG - Bulgaria 7
ET - Etiopia 7
HU - Ungheria 7
KZ - Kazakistan 7
LY - Libia 7
OM - Oman 7
SI - Slovenia 7
TT - Trinidad e Tobago 7
AO - Angola 6
BH - Bahrain 6
CI - Costa d'Avorio 6
GE - Georgia 6
IR - Iran 6
MG - Madagascar 6
QA - Qatar 6
AL - Albania 5
CG - Congo 5
GY - Guiana 5
HR - Croazia 5
MT - Malta 5
NO - Norvegia 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
BB - Barbados 4
DM - Dominica 4
Totale 45.019
Salva come PNG Salva come JPEG
Città #
Dallas 3.703
Singapore 2.359
Ashburn 1.427
Beijing 1.203
San Jose 1.176
Southend 907
Hong Kong 782
Chandler 733
Moscow 597
Fairfield 584
Los Angeles 571
Houston 541
Ho Chi Minh City 533
Woodbridge 469
San Mateo 436
Chicago 430
Ann Arbor 422
Falls Church 406
Seattle 363
Hanoi 358
Cambridge 332
Jacksonville 328
Wilmington 315
The Dalles 309
New York 304
Ottawa 255
São Paulo 234
Lauterbourg 224
Boardman 223
Hefei 216
Dearborn 214
Buffalo 194
Santa Clara 193
Dublin 188
Salt Lake City 177
Pisa 175
Portsmouth 170
Stevenage 164
Beauharnois 163
Tel Aviv 154
Warsaw 154
Milan 152
Orem 151
Munich 149
Dong Ket 147
Helsinki 142
Rome 141
London 133
Lawrence 132
Council Bluffs 118
Montreal 117
Brooklyn 113
Mexico City 100
Tokyo 98
Stockholm 92
Denver 91
Frankfurt am Main 88
Poplar 87
Atlanta 86
Chennai 85
Tampa 83
Istanbul 77
Amsterdam 75
Johannesburg 73
Da Nang 72
Montréal 72
Elk Grove Village 71
Rio de Janeiro 71
Toronto 67
Nuremberg 66
Phoenix 64
San Diego 63
Florence 61
Haiphong 60
Tashkent 55
Boston 54
Fremont 53
Manchester 48
Ankara 47
Guayaquil 47
San Francisco 46
Biên Hòa 45
Turku 44
Brasília 41
Lappeenranta 40
Redwood City 40
Belo Horizonte 39
Mumbai 39
Paris 37
Dongguan 36
Genoa 36
Baghdad 35
Bologna 35
Curitiba 35
Guangzhou 35
Porto Alegre 34
Quito 34
Sterling 34
Lancaster 33
Querétaro 32
Totale 26.937
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.673
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 553
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 482
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 390
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 360
A simple echocardiographic score to rule out cardiac amyloidosis 358
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 338
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 336
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 330
Central sleep apnea and cardiovascular disease state-of-the-art 326
A simple echocardiographic score to rule out cardiac amyloidosis 324
Treating chemoreflex in heart failure: modulation or demolition? 320
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 319
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 314
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 313
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 310
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 310
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 309
Adrenergic activation in heart failure: blockade or rebalance? 307
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 307
[Central apneas and cardiovascular diseases] 302
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 300
Prediction of the chemoreflex gain by common clinical variables in heart failure 296
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 289
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 289
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 288
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 287
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 279
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 273
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 269
How to take arms against central apneas in heart failure 268
Screening the health status of people working in a university 266
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 264
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 260
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 260
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 257
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 256
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 255
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 255
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 255
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 254
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 250
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 250
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 250
Improved survival in limited scleroderma-related pulmonary artery hypertension 249
An atypical case of cardiac amyloidosis. 247
B-type natriuretic peptide secretion following scuba diving 247
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 247
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 246
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 246
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 244
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 242
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 242
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 241
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 241
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 240
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 240
Eligibility for vericiguat in a real‐world, contemporary heart failure population 239
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 239
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 236
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 236
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 236
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 234
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 233
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 233
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 233
Role of Imaging in Cardiomyopathies 228
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 227
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 227
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 226
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 226
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 225
Central apnoeas and ticagrelor-related dyspnoea in patients with acute coronary syndrome 225
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 222
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 221
Prognostic value of plasma Renin activity in heart failure. 220
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 219
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 219
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 218
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 218
Breath-hold task induces temporal heterogeneity in electroencephalographic regional field power in healthy subjects 218
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 218
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 218
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 216
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases 215
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 215
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction 214
Exploratory analysis of nonlinear coupling between EEG global field power and end-tidal carbon dioxide in free breathing and breath-hold tasks 214
Reversal of ticagrelor-induced arrhythmias and cheyne-stokes respiration with aminophylline infusion 213
Renin profiling predicts neurohormonal response to sacubitril/valsartan 212
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 211
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 210
Pathophysiology of Central Apneas in Heart Failure 210
A Novel Workflow for Electrophysiology Studies in Patients with Brugada Syndrome 209
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 208
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure 206
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 206
Automatic analysis of EEG pattern during sleep in Cheyne-Stokesrespiration in heart failure. 206
Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance 205
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 205
Totale 27.392
Salva come PNG Salva come JPEG
Categoria #
all - tutte 216.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.551
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021861 0 0 0 0 0 0 0 0 0 207 198 456
2021/20222.330 146 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.696 65 80 466 207 596 585 1.383 2.351 871 949 1.993 1.150
2025/202622.595 1.363 4.006 2.931 3.638 2.944 1.612 2.391 1.058 1.413 1.239 0 0
Totale 45.373